Psychologists in New Castle, DE Accepting Medicare

56 Psychologists found. Showing 1 - 20

Kelsey Baldwin, M.A., ED.S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 801 Cox Neck Rd, New Castle, DE 19720 Phone: 302-832-6280

Robert Demerest Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2793

Mrs. Emily Klein, PSY Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2793    Fax: 302-323-2787

Olivia Aquino Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 1201 Delaware St, New Castle, DE 19720 Phone: 302-323-2926

Marissa Jane Franklin, M.S , ED.S Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2712

Meghan Naudasher, PSY Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700

Rose Agovino Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 20 Chase Ave, New Castle, DE 19720 Phone: 302-429-4000

Dr. Brian Michael Simon, PAY.D Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1901 N Dupont Hwy, New Castle, DE 19720 Phone: 302-255-2898

Teri B Lawler Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 160 Malcolm Forest Rd, New Castle, DE 19720 Phone: 302-743-5486    Fax: 302-327-4822

Linda C Peck, PSY Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-449-3602    Fax: 302-376-6796

Ingrid Carr Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700

Nicole Wertz Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700

Ms. Julie Watkins, PSY Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700

Ashley Schoenenberger Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-832-6330

Dianna Wambach, ED.S Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700

Kubra Tas Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700

Mr. Irven E Simpkins Jr., ED.S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700

Shradha Gera Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700

Mildred Appiah Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 148 Malcolm Forest Rd, New Castle, DE 19720 Phone: 302-310-2665

Tracey Tilghman Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700

News Archive

APP Pharmaceuticals receives FDA approval to market Aztreonam for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Aztreonam for Injection, USP in two dosage strengths. Aztreonam is therapeutically equivalent to the reference-listed drug Azactam, which is marketed by Bristol-Myers Squibb.

Study reveals connection between restless sleep and Parkinson's disease

A study published in the neurological journal, The Lancet Neurology, has identified that patients with rapid eye movement sleep behavior disorder (RBD) have a dopamine deficiency in the brain and suffer from a form of brain inflammation. They are subjected to increased risks of developing dementia or Parkinson's disease as they grow older.

Galectin Therapeutics fourth quarter net loss increases to $3.7 million

Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the full year and fourth quarter, ended December 31, 2011.

BRI scientists receive two major grant awards for research into autoimmunity prevention

Benaroya Research Institute at Virginia Mason (BRI) recently received two major grant awards to explore how to regulate the immune system, as part of a nationwide collaborative program to prevent autoimmune diseases.

Read more Medical News

› Verified 8 days ago

• 1(current)
• 2
• 3